Post by MINAKEM

🚀 Major milestone achieved for our vincas product range: PMDA validates our new vindesine API process in Japan! After three years of intense development, our teams have successfully designed an innovative manufacturing process that eliminates a critical HSE risk, replacing an explosive raw material with a much safer alternative. 👉 A breakthrough that combines process innovation, safety, and regulatory excellence This achievement would not have been possible without the strong collaboration with our Japanese Customer and the continuous support of our regulatory agent, EPS Corporation. 💊 Vindesine plays a key role in oncology, used alone or in combination therapies to treat various cancers, including leukemia, lymphoma, melanoma, breast cancer, and lung cancer. 👏 A great thanks to all teams involved in bringing this project to success — from R&D to regulatory and industrial operations! #Pharma #API #Oncology #Innovation #HSE #PMDA #GMP #Japan #Teamwork #ProcessDevelopment #vindesine